
Optimizing emergency care for neurotrauma patients
UC expert featured in Emergency Medicine News article
The University of Cincinnati's Natalie Kreitzer, MD, was featured in an Emergency Medicine News article discussing new practices to optimize emergency care for patients with traumatic brain injuries (TBI).
Kreitzer said one of the most significant updates is the recent availability of blood biomarker tests for mild TBI. The tests measure levels of two proteins released when neurons are injured.
Additionally, measuring pupillary light response with a new small, inexpensive device called a quantitative pupillometer can provide doctors with more precise data to make more informed decisions.
“It's something I would encourage emergency departments to use, particularly because some of those decisions will guide whether the patient is a candidate for surgery or ICP [intracranial pressure] monitoring and other things further down the road, particularly if you're working in an emergency department where you have to transfer those patients out,” said Kreitzer, associate professor in the Department of Emergency Medicine in UC's College of Medicine and a UC Health physician.
Read the Emergency Medicine News article.
Featured photo at top of a doctor pointing to a data point on a neurotrauma monitor. Photo/Andrew Higley/UC Marketing + Brand.
Related Stories
MedPage Today: Individual EMS agencies vary in stroke case documentation
December 22, 2022
The University of Cincinnati's Christopher Richards, MD, co-authored an accompanying editorial to new research that showed high variability in the way EMS agencies document stroke cases, which was recently featured by MedPage Today.
Know Stroke Podcast: UC physician discusses mobile stroke unit
April 28, 2023
The University of Cincinnati's Christopher T. Richards, MD, was a recent guest on the Know Stroke Podcast to discuss mobile stroke units and where research is headed to improve care.
WLWT: UC hosts RESET epilepsy trial
May 3, 2023
WLWT spoke with the University of Cincinnati's Brandon Foreman about a clinical trial testing a new treatment for status epilepticus, the most severe and deadly form of epilepsy.